Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 447,098 | 487,848 | 396,831 | 329,534 | 57,326 |
| Depreciation Amortization | 260,691 | 195,180 | 135,913 | 130,794 | 147,406 |
| Income taxes - deferred | -88,815 | -225,591 | -41,163 | -68,358 | -49,254 |
| Accounts receivable | -40,132 | 12,278 | -25,603 | -24,841 | -55,041 |
| Accounts payable and accrued liabilities | 17,040 | 214 | 361 | -2,280 | -37,966 |
| Other Working Capital | 21,083 | 26,766 | -20,864 | 1,038 | -60,509 |
| Other Operating Activity | 181,939 | 196,392 | 146,916 | 166,056 | 405,644 |
| Operating Cash Flow | $798,904 | $693,087 | $592,391 | $531,943 | $407,606 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -310,915 | -155,000 | -65,275 | 0 | N/A |
| PPE Investments | 27,528 | -28,950 | -9,687 | -35,958 | -36,347 |
| Net Acquisitions | N/A | N/A | -1,502,443 | 33,703 | -828,676 |
| Purchase Sale Intangibles | -111,100 | -85,000 | -173,750 | 0 | -202,626 |
| Other Investing Activity | -111,100 | -85,000 | -173,750 | 0 | -202,626 |
| Investing Cash Flow | $-394,487 | $-268,950 | $-1,751,155 | $-2,255 | $-1,067,649 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 559,393 | 994,647 | 898,642 | 1,194,385 |
| Debt Repayment | -25,717 | -886,094 | -178,304 | -1,065,760 | -309,524 |
| Common Stock Issued | 93,337 | 31,824 | 24,174 | 40,523 | 58,487 |
| Common Stock Repurchased | -523,672 | -98,799 | -278,296 | -61,553 | -42,215 |
| Other Financing Activity | -23,078 | -15,435 | -21,234 | -26,175 | -190,099 |
| Financing Cash Flow | $-479,130 | $-409,111 | $540,987 | $-214,323 | $711,034 |
| Exchange Rate Effect | -1,700 | 5,046 | -5,045 | -10,622 | -3,453 |
| Beginning Cash Position | 386,035 | 365,963 | 988,785 | 684,042 | 636,504 |
| End Cash Position | 309,622 | 386,035 | 365,963 | 988,785 | 684,042 |
| Net Cash Flow | $-76,413 | $20,072 | $-622,822 | $304,743 | $47,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | 798,904 | 693,087 | 592,391 | 531,943 | 407,606 |
| Capital Expenditure | -20,370 | -28,950 | -9,687 | -35,958 | -36,347 |
| Free Cash Flow | 778,534 | 664,137 | 582,704 | 495,985 | 371,259 |